425 - Doxycycline Post-Exposure Prophylaxis for STI’s – Where We Are Now and What the Future May Hold

Tuesday, October 21, 2025

2:10 PM - 2:35 PM US ET

Location: Sidney J. Marcus Auditorium

Speaker(s)

Kenneth H. Mayer, MD (he/him/his)

Medical Research Director
Fenway Health
Boston, MA, United States

Slides

Disclosure(s):

Kenneth H. Mayer, MD: Gilead Biosciences: Advisor/Consultant, Grant/Research Support; GSK/ViiV Healthcare: Advisor/Consultant, Grant/Research Support; Merck and Company, Inc.: Advisor/Consultant, Grant/Research Support; Moderna, Inc.: Grant/Research Support